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Since the original report by Boyden and Sorkin (1, 2)  that membranes of macro- 
phages bind  "cytophilic" antibody, numerous studies have described a  similar phe- 
nomenon in other cell types; viz., mast cells  (3); neutrophils  (4); murine tumor cells 
of the mastocytoma (5) and lymphoma types (6-8); various human tumor cells (9, 10) ; 
monocytes  (11);  and  lymphocytes  (12-14).  Studies  of immunoglobulin  binding  to 
lymphocytes by Basten et al.  (12,  13)  in mice and by Dickler  and Kunkel  (14)  in 
humans have shown that binding is characteristic of B cells and not of T  cells. How- 
ever, more recently it has been claimed that thymus-derived lymphocytes also bear 
receptors for immunoglobulin (15-17). 
The methods used  to study antibody binding by cell  membranes have generally 
utilized antigen-antibody complexes,  employing either a  particulate antigen such as 
sheep  erythrocytes or a  radiolabeled  antigen  such as  [x25I]chicken "y-globulin.  Non- 
specifically  aggregated IgG, which has been  shown  to possess  biological properties 
similar  or identical  to antigen-antibody complexes (18),  has also been used  (9,  14). 
These Ig aggregates, formed either with a bifunctional reagent such as BDB  1 or with 
heat, are distinctly advantageous in that preparation is simple and different immuno- 
globulin classes  and subclasses can be used to determine the  specificity of immuno- 
globulin interaction with cells. 
In the present study, using heat- and BDB-aggregated  mouse IgG, we have 
shown  that  both  B  and  T  lymphocytes bear  receptors  for immunoglobulin. 
Some of the characteristics of this binding phenomenon are described,  and the 
relative numbers of receptors on various cell types are compared. 
Materials and Methods 
Preparation of Cells.--Spleens and thymuses were obtained from 5-7-wk old male and female 
normal Balb/c mice. They were dissected free of extra-organ  tissue under magnification and 
were teased  apart with forceps in cold HBSS. Debris  and cell aggregates were allowed to 
* Supported by National Institutes of Health Grant AI-09758 and Allergy Disease Center 
Grant AI-10398. 
1  Abbreviations used in this paper: agg-141, aggregated  IgG2b (MOPC-141);  BDB, bis- 
diazotized benzidine; BSA, bovine serum albumin; CGG, chicken "},-globulin; HBSS, Hanks' 
balanced  salt  solution;  HGG,  human  T-globulin;  PBS,  phosphate-buffered  saline; SDS, 
sodium dodecylsulfate;  SIg,  surface immunoglobulin; 
THE  JOURNAL OF  EXPERIMENTAL MEDICINE • VOLUME 139,  1974  1175 1176  RECEPTORS  FOR  AGGREGATED  IgG  ON  T  CELLS 
settle out for 10 min at 4°C. The cells were then washed three times in HBSS. Viability was 
90% or greater.  For the isolation of macrophages female Baib/c mice were injected intra. 
peritoneaily with 1.5 ml of a  sterile 10% solution (wt/vol) of proteose peptone (Difco Lab- 
oratories, Detroit, Mich.) in saline (19). 3 days later macrophages were harvested by washing 
the periotoneal cavities with cold HBSS containing 0.03 M sodium azide and 10 U/ml heparin. 
Cells were washed three times in HBSS with azide. 80-85% of ceils were large mononuclear 
phagocytic cells.  Cells of both the murine mastocytoma P815 and the theta-posidve lym- 
phoma, L5178Y,  maintained in ascific form in DBA/2 mice, were obtained by paracentesis 
and washed three times in HBSS.  In order to obtain allogeneically activated thymus cells 
(20, 21), male BDF1  (C57/B16 X  DBA/2) mice were lethally irradiated with 1,100 R  from 
a  Co  6° source and within 2 h were infused intravenously with 50-60 X  106 thymocytes from 
5-7-wk old DBA/2 mice. On day 7 cells from recipient spleens were teased and washed in 
cold HBSS. 
Purification  of Proteins.--Mouse  myeloma  proteins  MOPC  141  (IbG2b),  MOPC  195 
(IgG2b), MOPC  21  (IgG1), and S  121  (IgA) were purified by starch block electrophoresis. 
In the case of S 121 further purification was obtained by gel filtration on Sephadex G-200. 
Cohn Fraction II of normal chicken serum was exhaustively absorbed with Balb/c thymus 
and spleen cells to remove heterophile activity. Absorbed CGG did not bind to mouse lym- 
phocytes when tested by indirect immunofluorescence. Bovine albumin powder,  fraction V 
from bovine plasma was obtained from Metrix (Armour and Co., Ltd., Eastbourne, England) 
lot J39404 and used without further purification. Human "),-globulin  was obtained by DEAE 
chromatography of Cohn Fraction II (obtained from the American Red Cross). Papain diges- 
tion of  mouse IgG and separation of Fab  and Fc  fragments was performed as previously 
described (22). 
Aggregation of Protdns.--Myeloma  proteins MOPC  141,  MOPC  195,  and  CGG at  con- 
centrations  of  2  mg/ml  in  PBS  were  heated  in  a  63 °  C  water  bath  until  barely 
visible opalescence was obtained. For CGG the time required for aggregation was less than 1 
rain, for MOPC 195 about 3 rain, and for MOPC 141 10-11 min. Alternatively, these proteins 
and others used in this study which did not readily form soluble aggregates upon heating were 
aggregated with BDB according to the method of Ishizaka (18).  It was found that by varying 
the relative concentrations of protein and BDB, large soluble aggregates could be obtained. 
BDB and heat-aggregated preparations of the same protein behaved similarly with respect to 
lymphocyte-binding capacity. 
Aggregates were radioiodinated with m5I by a  modification of the chloramine T  method 
(23).  Specific  activities ranged from 6-9/zCi//zg. Labeled aggregates were diluted  to a  con- 
centration of  5  /zg/ml in  10% heat-inactivated calf serum/HBSS  and were  centrifuged at 
3,000 rpm for 20 min immediately before use. 
The extent of aggregation was evaluated by Sepharose 4B gel filtration. For covalently 
linked  aggregates  3%  polyacrylamide gel  electrophoresis in  SDS was  also  performed  (8). 
Polyacrylamide gels were either stained with Coomasie blue or in the case of radiolabeled 
proteins were fractionated on an autogel divider (Savant Instruments, Inc., Hicksville, N. Y.) 
and counted in an automatic gamma scintillation counter. 
Binding Assay and Autoradiography.--Cells  prepared as described above were resuspended 
in 10% heat-inactivated calf serum/HBSS. To  10-20  X  106 cells aliquoted into 5-ml poly- 
styrene tubes was added 0.1 ml of the centrifuged radiolabeled aggregated protein solution 
(at 5 #g/ml), an amount calculated to be in aggregate excess. The mixture, in a total Volume of 
1 ml, was incubated in a  37  ° C  water bath for 1 hr. To test for inhibition of binding, the 
cells were first incubated for 10 rain at 37 ° C with 0.1 ml of unlabeled inhibitor protein at a 
concentration 500 times that of the radiolabeled test aggregate. The radiolabeled aggregate 
was  then added  and incubation at 37  ° C  continued for 1 hr. The cell suspension was  then 
diluted to 4 ml with cold medium and was centrifuged at 1,000 rpm for 10 min. The cell pellet 
was washed three times in medium, resuspended gently in 0.2 ml of medium, and smeared onto CLARK L.  ANDERSON AND HOWARD M.  GREY  1177 
gelatin-coated microsope slides. Slides were allowed to air dry, fixed for 30 rain in  1% glu- 
taraldehyde-PBS, washed for 30 rain in distilled water, and again air dried. Fixed and dried 
slides were dipped in NTB-2 emulsion and allowed to dry vertically. After varying periods of 
exposure, slides were developed and stained with Giemsa. Autoradiographs were analyzed by 
bright field microscopy. Between 200-300 cells were scored for the number of grains lying over 
or contiguous  with  the cell. In thymocyte and splenocyte preparations, only small mono- 
nuclear cells were scored, eliminating insofar as possible monocytes,  macrophages,  and poly- 
morphonuclear cells. In macrophage preparations, only large mononuclear cells with vacuolar 
cytoplasm were scored. Small lymphocytes and neutrophils were excluded. 
To study cell surface redistribution of bound [125I]agg-IgG,  lymphocytes were incubated 
at 0  ° C for 1 h with 0.1 ml of the radiolabeled aggregated preparation. Unbound  Ig was then 
removed by washing the cells three times with medium following which the cells were incubated 
at 37  ° C for varying periods of time. The cells were again washed and autoradiographs were 
made. Labeled cells were sorted into two groups: those with grains evenly situated about the 
cell perimeter and those with definite asymmetry of grain distribution. 
To determine the percentage of SIg,  + 8,  + and "Null" (SIg-, ~-) lymphocytes which bound 
[125I]agg-141, washed spleen cells were incubated first with [125I]agg-141 for 15 rain at 37 ° C. 
After three washes in cold HBSS, the cells were incubated either in a direct staining procedure 
with fluoresceinated rabbit antimouse Ig antiserum or in an indirect procedure with anti-theta 
antiserum (kindly supplied by Dr. John J. Cohen) as the first layer followed by fluoresceinated 
antimouse Ig antiserum as the second layer. The antiserum incubations were performed at 
0  ° C for 30 min in the presence of 0.03 M sodium azide. Cells were then prepared for auto- 
radiography as described above except that absolute methanol was used as a fixative rather 
than glutaraidehyde. Small round cells were  scored for both fluorescence and  grains.  The 
exposure times used in this experiment were chosen so that only cells with a relatively large 
number of agg-141 receptor sites would be scored as positive. 
RESULTS 
Binding of Radiolabeled Aggregated IgG to Lymphocytes.--To determine  the 
extent of binding of aggregated Ig to lymphocytes, cells were incubated for 1 h 
at  37°C  with  radioiodinated  (6-9/zC/#g)  heat-aggregated  mouse  IgG2b 
myeloma protein MOPC-141  ([125I]agg-141). This protein was selected because 
it readily formed soluble aggregates when heated at 63°C.  Cell suspensions of 
mouse thymus and spleen were incubated with 0.5 tzg of pSI]agg-141 and pre- 
pared for autoradiography. A  representative experiment is shown in Fig. 1, A. 
After 9 days of exposure about 70 % of spleen lymphocytes contained 6 or more 
grains,  a  grain  count  in  considerable excess  of background  and  significantly 
greater than  that obtained with spleen cells that had been preincubated with 
unlabeled  aggregated  MOPC-141  before  the  addition  of  the  radiolabeled 
preparation. After a very long exposure (5 mo) autoradiographs of spleen cells 
showed 75 % of highly labeled small lymphocytes with more than 30 grains/cell 
and another 10% having 16-30 grains/cell (Fig. 1, B). Only 1% of control cells 
(preblocked with unlabeled MOPC-141)  had 16 grains/cell or more. Therefore, 
about  85 %  of normal  spleen cells bound  significant amounts  of  [125I]agg-141. 
Since only 40-50 % of spleen cells were B  cells as judged by immunofluorescence 
for surface Ig, these data indicate that 30-40 %  of non-B  cells, presumably T 
cells, also have the capacity to bind aggregated Ig. This point is discussed in 
greater detail in a  subsequent section. 1178  RECEPTORS FOR AGGREGATED IgO  ON  T  CELLS 
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FIC-. I.  Splenocytes were exposed to [mSl]agg-141  for 60 rain at 37°C (hatched ba~). Cells 
were also incubated with 500-fold excess of unlabeled agg-141 before incubation with [~'6I]agg- 
141  (solid bars).  The grains associated with 200 small mononuclear cells were counted  and 
the number of grains per cell was plotted against per cent of cells so labeled. The grain count 
distribution  of an autoradiograph  exposed for 9 days is shown in A, whereas B represents the 
grain count distribution  after a 5-too exposure period. 
Thymus cells  were similarly studied  for their  capacity to bind  [12~I]agg-141 
(Fig. 2). After a 9-day exposure, 21% of thymocytes had 6 or more grains and 
31% had 3 or more grains,  whereas none of the control cells had more than 2 
grains/cell.  After  5  mo  exposure,  the  number  of specifically labeled  cells  in- 
creased to 45-50 %. There was a suggestion of a bimodal distribution with one 
population having a peak at 6-8 grains/cell and another population with more 
than 20 grains/cell. The percentage of thymus cells that bound agg-141 varied 
considerably from one experiment to another depending on both the exposure 
time  of  the  autoradiographs  and  the  particular  preparation  of  agg-141.  In 
general, with exposure times of 3-4 wk, 10-20 % of thymocytes bound agg-141. 
Specificity of Binding of Agg-141 to Lymphocytes.--Several parameters of the 
binding  of agg-IgG to lymphocytes were  investigated  to  obtain  information 
regarding the specificity of the interaction.  First,  the importance of aggregate 
size itself was studied. In order to study what degree of aggregation was neces- 
sary for binding, a preparation of BDB-aggregated MOPC-141 was fractionated 
on a  Sepharose  4B column.  A  protein peak was obtained in the void volume 
followed by a broad plateau which extended from the void volume to the position CLARK  L.  ANDERSON  AND  HOWARD  M.  GREY  1179 
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FIG. 2.  Thymocytes were exposed to [x25I]agg-t41 for 60 rain at 37°C (hatched bars). Cells 
were also incubated with 500-fold excess of unlabeled agg-141 before incubation with [125I]agg- 
141 (solid bars). The gains associated with 200 small mononuclear cells were counted and the 
number of grains per cell was plotted against per cent of cells so labeled. The grain count dis- 
tribution of an autoradiograph exposed for 9 days is shown in A, whereas B  represents the 
grain count distribution after a 5-too exposure period. 
of IgG monomer at which point another peak was observed. Two tubes, one 
close to the void volume and one close to the monomer peak, were chosen for 
further study. These two samples were iodinated, tested for binding to spleen 
and thymus lymphocytes, and analyzed for degree of aggregation by polyacryl- 
amide electrophoresis in SDS. Table I  contains the binding data together with 
the molecular weight information. Monomer 141  demonstrated no significant 
binding to either spleen or thymus lymphocytes. The fraction eluted just ahead 
of the monomer peak (Fr 2) had a mean aggregate size of three. Under condi- 
tions that  showed unfractionated BDB  agg-141  binding  to  40%  of  splenic 
lymphocytes and  8%  of  thymocytes, the  low molecular  weight  aggregates 
bound to only 5 %  of spleen cells  and  1%  of thymocytes. Fraction 1 of the 
Sepharose 4B column had a mean aggregate size of about 15 and bound to 31% 
of spleen cells but only 2 % of thymocytes. It is obvious from these studies that 
the degree of binding to lymphocytes is directly proportional to aggregate size 
and that the optimal size  is greater than 15  and probably is of a  size  large 
enough to be present in the void volume of the column, i.e., >_ 20,000,000. 
Next, purified preparations of other aggregated proteins were tested for their 
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TABLE I 
Lymphocyte Binding  of Aggregates of Different Molecular Size 
Preparation  Mean aggregate size 
Percentage of positive cells 
Spleen  Thymus 
%  % 
Unfractionated  ,~100  40  8 
(1 to >  100)* 
Sepharose Fr. 1  15  31  2 
(6-25) 
Sepharose Fr. 2  3  5  1 
(1-6) 
Monomer  1  0  0 
* Range of aggregate size. 
bovine serum albumin; a nonmammalian Ig, chicken T-globulin; and a mouse 
Ig not known to possess cytophilic properties, IgA, were used. All proteins were 
aggregated with heat or BDB and were shown by SDS polyacrylamide electro- 
phoresis to have aggregates comparable in size with agg-141. These aggregates 
were then  tested for lymphocyte binding by performing autoradiography on 
mouse lymphocytes either incubated directly with the radioiodinated prepara- 
tions or incubated first with unlabeled aggregated preparations and then with 
[125I]agg-141. Table II illustrates the capacity of the radiolabeled preparations 
to bind to spleen cells  and thymocytes. Besides BSA, mouse IgA,  and CGG, 
radiolabeled  aggregates  of  MOPC-141,  MOPC-21  (IgG1),  and  human  IgG 
were also tested. Whereas no significant binding occurred with IgA, BSA, or 
CGG, both IgG1 and HGG gave results fairly comparable with those obtained 
with  [1251]agg-141. The ability of unlabeled aggregated proteins to inhibit the 
binding  of  [125I]agg-141 to lymphocytes was  next studied,  and  the  data  are 
presented in Table III. All unlabeled proteins were added before the addition 
of [125I]agg-141, in 500-fold excess to the radiolabeled preparation. The homol- 
ogous protein, agg-141,  virtually abolished the capacity of the labeled prepara- 
tion to bind  to lymphocytes in  a  fashion similar to  that  previously demon- 
strated in Figs.  1 and 2. Another IgG2b protein, MOPC-195, was also an ef- 
fective inhibitor, as was the IgG1 protein, MOPC-21. Since only a single large 
concentration of unlabeled protein was used, subtle differences in the ability of 
these proteins to inhibit [125I]agg-141 binding to lymphocytes may have been 
present but not detected by this experiment. On the other hand, aggregates of 
BSA, CGG, and the FaD fragment  of MOPC-195 had no inhibitory capacity. 
Attempts to form soluble aggregates of  the Fc fragment of an IgG2b protein 
have not been successful to date so it has not been possible  to evaluate the 
binding capacity of this fragment. Partial inhibition was obtained with the IgA CLARK L. ANDERSON AND HOWARD M.  GREY 
TABLE II 
Specificity of Binding of [125_I]A  ggregated Protein* to Mouse Lymphocyte~ 
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Exp.  Aggregate 
Percentage of positive cells 
Spleen  Thymus 
%  % 
IgG2b (MOPC 141)  45  11 
IgA (S 121)  0  0 
BSA  4  0 
CGG  1  0 
2  IgG2b (MOPC 141)  57  12 
IgG1 (MOPC 21)  34  5 
3  IgG2b (MOPC 141)  38  7 
HGG  40  2 
TABLE III 
Inhibition of Binding of [1251]Agg-141 to Mouse Lymphocytes by Unlabeled Protein Aggregates 
Exp.  Inhibiting aggregate 
Percentage of positive cells 
Spleen  Thymus 
%  % 
None  26  15 
IgG2b (MOPC 141)  1  0 
IgA (S 121)  19  9 
BSA  37  t6 
CGG  20  23 
None  45  17 
IgG2b (MOPC 195)  2  0 
Fab (MOPC 195)  43  12 
None  50  17 
IgG1 (MOPC 21)  11  0 
preparation.  This might have been  due to a relatively weak capacity of IgA to 
bind  to the IgG receptor  site  on lymphocytes, or alternatively,  due  to trace 
contamination of this preparation with IgG. 
From these data it can be concluded that lymphocyte binding of agg-141 is 
specific in that it is  a  property unique to the  aggregated form of the protein 
and is not shared by the aggregates of several other unrelated proteins such as 
BSA,  CGG,  and IgA. It is,  however,  a  reaction  which is  shared  with  closely 
related  proteins  such  as  another  IgG2b  protein,  IgG1,  and  another  mam- 
malian IgG protein, HGG. Although the data are consistent with the binding 
site being localized to the Fc fragment, a direct demonstration of this is thus far 
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Effect of Temperature on the Binding of [125I]Agg-141 to Lymphocytes.--The 
capacity of spleen and thymus cells to bind [l~sI]agg-141 was tested at 0  and 
37°C. As shown in Table IV, except for a single experiment with spleen cells, 
binding at 37°C  was  considerably greater than at 0°C. Optimal binding was 
observed after 15 min incubation at 37°C, whereas no clear plateau of binding 
was obtained at 0°C, even after 4 h  of incubation. Binding experiments were 
also performed at 13 and 25°C. Somewhat inconsistent results were obtained at 
these temperatures. In some experiments the degree of binding was equal to 
that observed at 37°C, whereas in others a moderate decrease in the binding 
capacity was observed. 
Distribution of Agg-IgG Binding Sites on the Surface of Lymphocytes.--The 
distribution of grains on the surface of lymphocytes that contained receptors for 
agg-IgG was studied, since it was apparent that under the standard conditions 
of incubation at 37°C,  many cells had  an  asymmetric distribution  of grains 
TABLE  IV 
Effect of Temperature  on the Binding of [1251] Agg-141 to Mouse Lymphocytes 
Percentage of labded cells 
Temperature  Exp:  Spleen  Thymus 
1  2  3  I  2  3 
°C  % 
0  8  49  27  1  7  0 
37  60  54  --  30  18  15 
reminiscent of the "capping" phenomenon. To study the temperature require- 
ments for this phenomenon, both thymus and spleen cells were incubated with 
[mI]agg-141 at 0°C for 1 h, washed, incubated at 37°C for varying lengths of 
times up to 120 rain, after which the cells were rapidly cooled to 0°C and pre- 
pared for autoradiography. Although few thymocytes bound  [125I]agg-141 at 
0°C,  as shown in Table V,  the proportion of labeled cells with  eccentrically 
placed grains was high before any 37°C incubation and was not increased by 
warming. In contrast, capping of labeled spleen cells increased from about 20 % 
to over 80%  by incubation  at 37°C. It is obvious from these data that  the 
majority of spleen cells undergo redistribution of receptor sites from a random 
distribution to a capped one following incubation at 37°C. The situation with 
thymocytes is more difficult to assess since an asymmetric distribution of grains 
was observed under all conditions of study. No conclusion can be made as to 
whether  the  observed  caps  on  thymocytes  represented  a  redistribution  of 
binding sites or whether the binding sites were asymmetrically disposed on the 
cell surface before their binding agg-IgG. 
Comparison of Agg-IgG Binding by Different Cell Types.--To determine the CLARK  L.  ANDERSON  AND  HOWARD  M.  GREY 
TABLE V 
Capping of [125I]Agg-141 on the Surface of Mouse Lympkocytes 
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Time at 37°C 
Percentage of labeled cells capped 
Spleen  Thymus 
min  %  % 
0  20  75 
10  17  71 
20  61  -- 
30  78  -- 
60  83  73 
110  86  -- 
relative degree of binding of agg-IgG by various types of cells,  the following 
experiment was performed. The mouse cells chosen for study were: mastocy- 
toma P815; macrophages obtained from peritoneal exudates; the theta-posifive 
DBA/2  lymphoma  L5178Y;  Balb/c  spleen  cells;  Balb/c  thymocytes;  and 
spleen cells obtained from irradiated BDF1 mice 7 days after they were injected 
with parental DBA/2 thymocytes. These preparations were all incubated with 
[125I]agg-141. Macrophages  were  incubated  at  0°C  to prevent phagocytosis, 
whereas all the other cell types were incubated at 37°C. Autoradiographs were 
developed after varying exposure times in order to have significant numbers of 
grains for each cell type. Grain counts were then normalized for time of ex- 
posure and  expressed as grains/cell/day of exposure. Fig.  3  illustrates  these 
results. The data are plotted as the cumulative percentage of cells having a 
certain grain count or more. Macrophages and the P815 mastocytoma bound 
the most [125I]agg-141 with an average of 40-50 grains/cell/day. An average of 
20-30 grains/cell/day was seen on labeled allogeneically activated thymus cells. 
Spleen lymphocytes had a small population of high binding cells with the bulk 
of cells having an average of 2-3-grains/cell/day. The positive population of 
thymocytes had about 0.6 grains/cell/day and the L5178 lymphoma was some- 
what higher with about 1 grain/cell/day. 
In  order  to determine the  relative binding  capacity of subpopulations  of 
splenic lymphocytes, the following double-labeling experiment was performed. 
Cells were first incubated with  [12~I]agg-141 for 15 min at 37°C. Mter being 
washed they were then incubated with either fluorescein-labeled rabbit  anti- 
mouse  Ig  or  anti-theta  antiserum  followed by  antimouse  Ig.  This  allowed 
enumeration  of  agg-141-positive  cells  simultaneously  with  SIg  as  a  B-cell 
marker and theta as a T-cell marker. The data are shown in Table VI. Mter 
4  days of exposure about 60%  of lymphocytes bound  agg-141. At this time 
approximately 80 % of B cells, as measured by their being SIg  +, bound agg-141; 
30% of theta-positive cells bound agg-141; and 55 % of "null" cells (SIg-, 0-) 
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FIG. 3.  Cells of various types were incubated at 37°C for 60 min (macrophages with azide 
at 0  ° C rather than 37 ° C)  and autoradiographs were prepared. Grains/cell/day are plotted 
against the cumulative percentage of cells with a certain grain count or greater on  the ver- 
tical axis.  (O--O),  macrophages;  (O--O),  P815  mastocytoma; (A--A), allogeneically 
activated T  cells; (&--&), normal spleen cells;  (B--I),  L5178Y  lymphoma; and ([::]--[2]), 
normal thymus. Horizontal lines above each curve represent the maximum percentage of 
positive cells obtained. 
TABLE  VI 
Distribution  of Agg-IgG-Binding  Cells Between SIg  "~, 8  +, and Null Spleen Cells 
Percentage of cells 
[125I]agg-141 positive  [1~I] agg-141 negative 
%  % 
sig-~  33  6 
SIg-  27  34 
SIg+0  +  33  31 
SIg-~-  14  11 
8  +  11  25 
(SIg+8  +  -- SIg  +) 
DISCUSSION 
Utilizing a sensitive autoradiographic assay to detect binding of l~SI-labeled 
heat-aggregated mouse IgG to various cell types, we have detected receptors 
for agg IgG on 70-85 % of mouse spleen cells and 20-45 % of thymus. Moreover, 
it has been possible to demonstrate similar receptor sites on the theta-positive 
lymphoma cell line, L5178,  as  well  as on spleen cells obtained from lethally 
irradiated  FI  hybrid  mice  infused  with  parental  thymocytes.  Simultaneous 
labeling of surface Ig, theta antigen, and receptor sites for agg-IgG has demon- 
strated that the majority of B lymphocytes possess a relatively high density of 
receptor sites for aggregated IgG. A subpopulation of theta-positive cells also 
possess relatively large numbers of receptors as does a subpopulation of SIg-, CLARK  L.  ANDERSON  AND  HOWARD  M.  GREY  1185 
0--, null  cells. There are  two aspects of our study which need to be focused 
upon before discussing these results in relation to previous studies.  First,  as 
shown in Fig. 3, there is a great deal of heterogeneity in the number of agg IgG 
receptor sites when different cell types are compared. For instance, there is ap- 
proximately a 100-fold difference in binding capacity between thymocytes and 
macrophages  or P815  mastocytoma cells.  Even  within  a  tissue  such  as  the 
spleen there is at least a 10-fold difference in receptor density when individual 
cells are compared. Second, besides having to prolong exposure times to detect 
cells with low receptor density, it was also necessary to use large sized aggre- 
gates. Our data indicate that optimal binding was obtained with aggregates in 
or near the exclusion volume of a Sepharose 4B column, i.e., of a size 20 million 
or more. This finding concurs with the data of Dickler and Kunkel (14)  who 
found that aggregates of greater than 300S  had to be used to obtain optimal 
binding to human B  cells. 
These  factors--heterogeneity of  numbers  of  receptors  on  different  cells, 
importance of aggregate size, and sensitivity of the detection system--may, at 
least in part, explain why our results differ from those of others whose work has 
indicated that IgG receptor sites were limited to bone marrow derived lympho- 
cytes. The reports of Basten et al. (12, 13) which indicated that binding of Ig 
was a property limited to B lymphocytes (although 2-4 % of C57/B16 thymo- 
cytes were also positive) does not permit an analysis of aggregate size since 
undefined ratios  of antigen  and  antibody were used  to form the  aggregates 
assayed for in their systems. With respect to sensitivity of assay, species and 
tissues studied, their system was similar to that we employed. Bentwich et al. 
(24)  used similar sized aggregates, but a different, perhaps less  sensitive, test 
system (immunofluorescence). Also their studies were done on human peripheral 
blood lymphocytes, whereas ours were performed on mouse spleen and thymus. 
It is difficult to assess  which of these several differences between laboratories 
may account for the higher degree of B-cell specificity of the agg IgG receptor 
in the Bentwich et al. study (2-4 % of T  cells,  as measured by their capacity 
to form rosettes with sheep erythrocytes, also bound agg-IgG) and the lack of 
such specificity in our study. The possibility that in peripheral  blood the agg 
IgG receptor is primarily associated with B cells, whereas in the spleen it is not, 
is considered a real one since in a previous study on the  occurrence of surface 
immunoglobulin and complement receptors (25), it was found that whereas in 
peripheral  blood  the  complement receptor was  found  almost  exclusively on 
SIg  + cells,  in the spleen there was  a  significant population of cells that were 
SIg- complement receptor positive. 
As mentioned above, although our results  are at variance with previous re- 
ports indicating that only B  cells bear receptor sites for IgG, there are other 
studies  which  support  our data  that  lymphoid cells other  than  B  cells  also 
possess  such  a  receptor. Previous studies  with  the  theta-positive lymphoma 
L5178 (8) as well as with another theta-positive lymphoma (6) have shown such 1186  RECEPTORS  FOR  AGGREGATED  IgG  ON"  T  CELLS 
receptor  sites  on  these  cells.  Secondly, using  a  rosette  assay,  Yoshida  and 
Anderson (15) have also shown that a high percentage of activated T  cells form 
rosettes with sheep cells coated with IgG antibody. Orr and  Paraskevas (16) 
also have data suggestive of the presence of receptor sites for IgG on the surface 
of T  cells. Moreover, Webb and Cooper (17) have demonstrated the capacity 
of thymocytes and blood lymphocytes from bursectomized birds depleted of 
B cells to form rosettes with sheep cells coated with IgM antisheep erythrocyte 
antibody, indicating receptors for IgM on the surface of non-B lymphocytes. 
Experiments to test for the presence of aggregated IgM receptor sites in our 
system have not as yet been possible due to the lack of suitable aggregated IgM 
preparations. Work by Greenberg et al. (26, 27) studying antibody-dependent, 
cell-mediated cytotoxicity suggests that a  non-B, non-T lymphoid cell  with 
sedimentation  velocity  characteristics  of  nonphagocytic  monocytes  is  the 
effector cell in this reaction. It is likely that some of the non-B non-T cells that 
we have detected by our aggregated IgG assay are similar to the cytotoxic cells 
that Greenberg describes. 
The difference between the density of receptor sites on normal spleen cells 
as  compared  with  spleen  cells  obtained  from  animals  injected  with  semi- 
allogeneic parental cells  was striking. Whether this represents  an increase in 
receptor density following activation of T  cells or is merely a characteristic of 
any proliferating lymphocyte population has not as yet been determined, and 
experiments to further investigate this phenomenon are underway. 
Finally, the  existence of IgG receptors  on  some  T  cells  accentuates  the 
problem of evaluating the presence of small amounts of T-cell-associated Ig as a 
possible synthetic product of T  cells. Moreover, the use of this receptor as a 
means of eliminating B cells from a mixed population of lymphocytes must be 
done with the understanding that a receptor-bearing subpopulation of non-B 
cells, perhaps functionally important, may also be removed. 
SUMMARY 
An autoradiographic  binding  assay  employing 1251-1abeled  heat-aggregated 
mouse  IgG2b myeloma protein  (MOPC 141)  was  used  to  demonstrate  receptors 
for  IgG on 20-45  % of  Balb/c thymocytes and on 70-80  % of  splenocytes.  Bind- 
ing  could  also  be  shown with  heat  or  BDB aggregates  of  another IgG2b (MOPC 
195),  with IgGl and with human ~,-globulin,  but not with aggregated  chicken 
~,-globulin,  IgA,  BSA, nor with aggregated  Fab fragments  of  IgG2b. Optimum 
binding  was obtained  at  37°C.  Detection  of  binding  was dependent upon aggre- 
gate  size  with complexes  of  more than I00 IgG molecules  being  optimal,  aggre- 
gates  of  6-25 detecting  splenocytes  but not thymocytes,  and aggregates  of  less 
than 6  binding  to  a  negligible  extent.  Comparison of  grain  counts  on  various  cell 
types showed mastocytoma cells  (P815) and macrophages  averaging  40-50 
grains/cell/day,  allogeneically  activated  thymocytes 20-30, splenocytes  2-3, 
L5178 lymphoma cells  I, and positive  thymocytes 0.6  grains/ce11/day.  Double CLARK  L.  ANDERSON  AND  HOWARD  M.  GREY  1187 
labeling experiments for surface Ig, 0-antigen, and agg IgG receptor on mouse 
spleen cells indicated  that a relatively high density of receptor was present on 
about 80 %  of B  cells, 30 %  of T  cells, and 60 %  of SIg-, 0--, null cells. 
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